FHIR IG analytics
Rows 0 - 200 Next
| Package | Identity | Name/Title | Status | FMM | WG | Date | Auth | Usage # |
|---|---|---|---|---|---|---|---|---|
| hl7.fhir.uv.vulcan-schedule | ActivityDefinition/ActivityDefinition-H2Q-MC-LZZT-Vital-Signs-Temperature.json | Vital Signs - Temperature | active | 2026-08 | hl7 | |||
| hl7.fhir.uv.ebm | ActivityDefinition/ActivityDefinition-375181.json | Candesartan 8 mg once daily | active | 2026-10 | hl7 | |||
| hl7.fhir.uv.ebm | ActivityDefinition/ActivityDefinition-213.json | IV remdesivir 200 mg then 100 mg/day for 9 days | active | 2021-11 | hl7 | |||
| hl7.fhir.uv.ebm | ActivityDefinition/ActivityDefinition-375159.json | Quadpill once daily | active | 2026-10 | hl7 | |||
| hl7.fhir.uv.imaging-service-request-ig | CapabilityStatement/CapabilityStatement-MwlManagerCapabilityStatement.json | Modality Worklist Manager CapabilityStatement | draft | ii | 2026-09 | hl7 | ||
| hl7.fhir.uv.imaging-service-request-ig | CapabilityStatement/CapabilityStatement-RisCapabilityStatement.json | RIS CapabilityStatement | draft | ii | 2024-05 | hl7 | ||
| hl7.fhir.uv.ehrs-rle | CapabilityStatement/CapabilityStatement-conformance-ehrs-rle.json | EHRS Functional Model - Record Lifecycle Events - Capability Statement | informative | 1 | ehr | 2025-01 | hl7 | |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-deviceusage-status.json | Device Usage Status | trial-use | 0 | oo | 2021-01 | hl7 | 8 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-deviceusage-adherence-reason.json | Device Usage Adherence Reason | trial-use | 0 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-deviceusage-adherence-code.json | Device Usage Adherence Code | trial-use | 0 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-ncbi-taxonomy-fragment.json | NCBI Taxonomy (fragment) | trial-use | 1 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.phx-incubator | CodeSystem/CodeSystem-seriousness-criteria.json | Seriousness Criteria Code System | trial-use | 1 | phx | 2022-06 | hl7 | |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-biologicallyderivedproductdispense-match-status.json | Biologically Derived Product Dispense Match Status | informative | 1 | oo | 2023-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-biologicallyderivedproductdispense-origin-relationship.json | Biologically Derived Product Dispense Origin Relationship | informative | 1 | oo | 2023-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-biologicallyderivedproductdispense-performer-function.json | Biologically Derived Product Dispense Performer Function | informative | 1 | oo | 2023-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-biologicallyderivedproductdispense-status.json | Biologically Derived Product Dispense Status Codes | informative | 1 | oo | 2026-10 | hl7 | 5 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-encodings.json | Encodings | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-moleculardefinition-literal-encoding.json | Molecular Definition Literal Encoding | informative | 1 | cg | 2025-01 | hl7 | 1 |
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-research-study-document-types-code-system.json | Research Study Document Types Code System | trial-use | 1 | cds | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-search-strategy-characteristic-code-system.json | Search Strategy Characteristic Code System | trial-use | 1 | cds | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-evidence-rating-system-classifier-codesystem.json | Evidence Rating System Classifier Code System | trial-use | 1 | cds | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-desirability-codesystem.json | Desirability Code System | trial-use | 1 | cds | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.admin-incubator | CodeSystem/CodeSystem-chargeitem-status.json | Charge Item Status | trial-use | 0 | pa | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.dap | CodeSystem/CodeSystem-permission-status.json | Permission Status | trial-use | 0 | sec | 2021-01 | hl7 | 6 |
| hl7.fhir.uv.fm-incubator | CodeSystem/CodeSystem-invoice-status.json | Invoice Status | trial-use | 0 | fm | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.dap | CodeSystem/CodeSystem-permission-rule-combining.json | Permission Rule Combining | trial-use | 0 | sec | 2022-08 | hl7 | 5 |
| hl7.fhir.uv.admin-incubator | CodeSystem/CodeSystem-invoice-priceComponentType.json | Invoice Price Component Type | trial-use | 0 | pa | 2021-01 | hl7 | 7 |
| hl7.fhir.uv.pharmaceutical-research-protocol | CodeSystem/CodeSystem-narrative-elements-cs.json | Narrative Elements Code System | trial-use | 0 | brr | 2025-08 | hl7 | 1 |
| hl7.fhir.uv.api-incubator | CodeSystem/CodeSystem-graph-compartment-use.json | Graph Compartment Use | trial-use | 1 | fhir | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-devicedispense-status.json | DeviceDispense Status | trial-use | 1 | oo | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-devicedispense-status-reason.json | DeviceDispense Status Reason | trial-use | 1 | oo | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-transport-intent.json | Transport Intent Code System | trial-use | 2 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-moleculardefinition-type.json | Molecular Definition Type CodeSystem | informative | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-transport-code.json | Transport Code | trial-use | 1 | oo | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-transport.json | Transport Code System | trial-use | 1 | oo | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.sql-on-fhir | CodeSystem/CodeSystem-ExportStatusCodes.json | Export Status Code System | trial-use | 2 | fhir | 2026-08 | hl7 | 1 |
| hl7.fhir.uv.phx-incubator | CodeSystem/CodeSystem-formularyitem-status.json | FormularyItem Status Codes | trial-use | 0 | phx | 2026-09 | hl7 | |
| hl7.fhir.uv.api-incubator | CodeSystem/CodeSystem-graph-compartment-rule.json | Graph Compartment Rule | trial-use | 1 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.mapping-language | CodeSystem/CodeSystem-map-transform.json | Structure Map Transform | trial-use | 2 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.mapping-language | CodeSystem/CodeSystem-map-model-mode.json | Structure Map Model Mode | trial-use | 2 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.mapping-language | CodeSystem/CodeSystem-map-target-list-mode.json | Structure Map Target List Mode | trial-use | 2 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.mapping-language | CodeSystem/CodeSystem-map-source-list-mode.json | Structure Map Source List Mode | trial-use | 2 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.mapping-language | CodeSystem/CodeSystem-map-group-type-mode.json | Structure Map Group Type Mode | trial-use | 2 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-inventoryitem-nametype.json | InventoryItem Name Type | trial-use | 1 | oo | 2026-10 | hl7 | 5 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-inventoryitem-status.json | InventoryItem Status Codes | trial-use | 1 | oo | 2026-10 | hl7 | 5 |
| hl7.fhir.uv.pc-incubator | CodeSystem/CodeSystem-condition-precondition-type.json | Condition Precondition Type | trial-use | 0 | pc | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.sql-on-fhir | CodeSystem/CodeSystem-LibraryTypesCodes.json | SQL Library Types Code System | trial-use | 2 | fhir | 2026-08 | hl7 | |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-normalization-method.json | Normalization Method | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.mapping-language | CodeSystem/CodeSystem-map-input-mode.json | Structure Map Input Mode | trial-use | 2 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-molecular-definition-focus.json | Molecular Definition Focus | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-strand-orientation.json | Strand Orientation | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.sql-on-fhir | CodeSystem/CodeSystem-OutputFormatCodes.json | Output Format Code System | trial-use | 2 | fhir | 2026-08 | hl7 | 2 |
| hl7.fhir.uv.sql-on-fhir | CodeSystem/CodeSystem-SQLContentTypeCodes.json | SQL Content Type Codes | trial-use | 2 | fhir | 2026-08 | hl7 | 1 |
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-ebmonfhir-profile-name-code-system.json | EBMonFHIR Profile Name Code System | trial-use | 1 | cds | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.ebm-incubator | CodeSystem/CodeSystem-publicationrecord-status-type.json | PublicationRecord Status Type | trial-use | 0 | cds | 2021-03 | hl7 | 1 |
| hl7.fhir.uv.ehrs-rle | CodeSystem/CodeSystem-record-lifecycle-events.json | CodeSystem record-lifecycle-events | informative | 1 | ehr | 2025-01 | hl7 | |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-coordinate-origin.json | Coordinate Origin | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-amino-acid.json | Amino Acid Symbols | informative | 0 | cg | 2026-03 | hl7 | 4 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-amino-acid.json | Amino Acid Symbols | draft | 0 | cg | 2026-03 | hl7 | 4 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-nucleotide-dna.json | Nucleotide DNA Symbols | informative | 0 | cg | 2026-03 | hl7 | 3 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-nucleotide-dna.json | Nucleotide DNA Symbols | draft | 0 | cg | 2026-03 | hl7 | 3 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-nucleotide-rna.json | Nucleotide RNA Symbols | informative | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-nucleotide-rna.json | Nucleotide RNA Symbols | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-supplydelivery-stage.json | Supply Delivery Stage | trial-use | 1 | oo | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-supplydelivery-status.json | Supply Delivery Status | trial-use | 1 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-supplydelivery-supplyitemcondition.json | Supply Delivery Supply Item Condition | trial-use | 1 | oo | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-supplydelivery-supplyitemtype.json | Supply Delivery Supply Item Type | trial-use | 1 | oo | 2021-01 | hl7 | 10 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-supplyrequest-status.json | Supply Request Status | trial-use | 1 | oo | 2021-01 | hl7 | 7 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-transport-status-reason.json | Transport Status Reason Code System | trial-use | 1 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-transport-status.json | Transport Status Code System | trial-use | 1 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-topology.json | Topology | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-testplan-assertion-type.json | Test Plan Assertion Type | draft | 0 | fhir | 2025-02 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-testplan-script-language.json | Test Plan Script Language | draft | 0 | fhir | 2025-02 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-http-operations.json | Test Script Request Method Code | draft | 4 | fhir | 2021-01 | hl7 | 3 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-moleculardefinition-moleculetype.json | Molecular Definition Molecule Type CodeSystem | informative | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-genomicstudy-changetype.json | Genomic Study Change Type | draft | 1 | cg | 2022-08 | hl7 | 1 |
| hl7.fhir.uv.dap | CodeSystem/CodeSystem-MyOrgRolesCS.json | MyOrg defined Roles CodeSystem | trial-use | 1 | sec | 2026-10 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-report-status-codes.json | Test Report Status | draft | 1 | fhir | 2021-01 | hl7 | 3 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-genomicstudy-dataformat.json | Genomic Study Data Format | draft | 1 | cg | 2022-08 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-moleculardefinition-representation-focus.json | Molecular Definition Representation Focus | informative | 1 | cg | 2025-01 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-testscript-scope-conformance-codes.json | Test Script Scope Conformance Type | draft | 4 | fhir | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-genomicstudy-methodtype.json | Genomic Study Method Type | draft | 1 | cg | 2022-08 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-coordinatesystem-normalizationmethod.json | Coordinate System Normalization Method CodeSystem | informative | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-testscript-scope-phase-codes.json | Test Script Scope Phase Type | draft | 4 | fhir | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-coordinatesystem-origin.json | Coordinate System Origin CodeSystem | informative | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-report-result-codes.json | Test Report Result | draft | 1 | fhir | 2021-01 | hl7 | 3 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-report-action-result-codes.json | Test Report Action Result | draft | 1 | fhir | 2021-01 | hl7 | 3 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-genomicstudy-status.json | Genomic Study Status | draft | 1 | cg | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-inventoryreport-status.json | Inventory Report Status | trial-use | 0 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-testplan-status.json | Test Plan Status | draft | 0 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-moleculardefinition-strand.json | Molecular Definition Strand CodeSystem | informative | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-moleculardefinition-topology.json | Molecular Definition Topology CodeSystem | informative | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-testplan-counttype.json | Inventory Count Type | draft | 0 | fhir | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.oo-incubator | CodeSystem/CodeSystem-inventoryreport-counttype.json | Inventory Count Type | trial-use | 0 | oo | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-assert-direction-codes.json | Assertion Direction Type | draft | 4 | fhir | 2021-01 | hl7 | 4 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-assert-manual-completion-codes.json | Assertion Manual Completion Type | draft | 4 | fhir | 2022-12 | hl7 | 5 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-assert-operator-codes.json | Assertion Operator Type | draft | 4 | fhir | 2021-01 | hl7 | 11 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-report-participant-type.json | Test Report Participant Type | draft | 1 | fhir | 2021-01 | hl7 | 3 |
| hl7.fhir.uv.testing | CodeSystem/CodeSystem-assert-response-code-types.json | Assertion Response Types | draft | 4 | fhir | 2021-01 | hl7 | 19 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-genomicstudy-regiontype.json | Genomic Study Region Type | draft | 1 | cg | 2026-09 | hl7 | 1 |
| hl7.fhir.uv.cg-incubator | CodeSystem/CodeSystem-genomicstudy-type.json | Genomic Study Type | draft | 1 | cg | 2022-08 | hl7 | 1 |
| hl7.fhir.uv.pc-incubator | CodeSystem/CodeSystem-condition-questionnaire-purpose.json | Condition Questionnaire Purpose | trial-use | 0 | pc | 2021-01 | hl7 | 5 |
| hl7.fhir.uv.admin-incubator | CodeSystem/CodeSystem-verificationresult-status.json | status | trial-use | 3 | pa | 2018-06 | hl7 | |
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-419455.json | ResearchStudy Classifier Code System | active | 2026-10 | hl7 | 1 | ||
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-179423.json | Evidence Based Medicine on FHIR Implementation Guide Code System | active | 2026-10 | hl7 | 3 | ||
| hl7.fhir.uv.clinical-study-protocol | CodeSystem/CodeSystem-ncit-cs.json | Fragment of NCIT Code System | trial-use | 2 | brr | 2026-06 | hl7 | 262 |
| hl7.fhir.uv.ebm | CodeSystem/CodeSystem-27834.json | Recommendation Justification Code System | active | 2022-02 | hl7 | 1 | ||
| hl7.fhir.uv.fm-incubator | CodeSystem/CodeSystem-enrollment-outcome.json | Claim Processing Codes | trial-use | 2 | fm | 2026-09 | hl7 | 1 |
| hl7.fhir.uv.molecular-definition-data-types | CodeSystem/CodeSystem-molecule-type.json | Molecule Type | draft | 0 | cg | 2026-03 | hl7 | 1 |
| hl7.fhir.uv.pc-incubator | CodeSystem/CodeSystem-linkage-type.json | Linkage Type | trial-use | 0 | pc | 2021-01 | hl7 | 1 |
| hl7.fhir.uv.imaging-service-request-ig | ConceptMap/ConceptMap-hl7v2-orm-to-fhir.json | ConceptMap - Populating FHIR Resources from HL7 v2.3.1 ORM/OMG Order Messages | draft | ii | 2026-09 | hl7 | ||
| hl7.fhir.uv.imaging-service-request-ig | ConceptMap/ConceptMap-fhir-to-dicom-imaging-service-request.json | ConceptMap - Populating DICOM Imaging Service Request from FHIR | draft | ii | 2026-09 | hl7 | ||
| hl7.fhir.uv.imaging-service-request-ig | ConceptMap/ConceptMap-mwl-entry-from-fhir.json | ConceptMap - Populating DICOM Modality Worklist C-FIND Response from FHIR | draft | ii | 2026-09 | hl7 | ||
| hl7.fhir.uv.imaging-service-request-ig | ConceptMap/ConceptMap-fhir-to-dicom-practitioner.json | ConceptMap - Populating DICOM Referring / Requesting Physician from FHIR | draft | ii | 2026-09 | hl7 | ||
| hl7.fhir.uv.imaging-service-request-ig | ConceptMap/ConceptMap-fhir-to-dicom-requested-procedure.json | ConceptMap - Populating DICOM Requested Procedure from FHIR | draft | ii | 2026-09 | hl7 | ||
| hl7.fhir.uv.imaging-service-request-ig | ConceptMap/ConceptMap-fhir-to-dicom-organization.json | ConceptMap - Populating DICOM Requesting Service / Entering Organization from FHIR | draft | ii | 2026-09 | hl7 | ||
| hl7.fhir.uv.api-incubator | GraphDefinition/GraphDefinition-example.json | Document Generation Template | draft | 2015-08 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-179619.json | SystematicReviewEligibilityCriteria: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179897.json | ConceptualCohortDefinition: Estimated glomerular filtration rate 45-59 | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-172424.json | ConceptualComparatorDefinition: NOT Bariatric Surgery (RYGB, VSG, LAGB, BPD) | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-264328.json | Search Strategy for NMA_Diabetes | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-172423.json | ConceptualExposureDefinition: Bariatric Surgery (RYGB, VSG, LAGB, BPD) | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179514.json | ConceptualCohortDefinition: BMI 27.5-32.4 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities without surgery | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179513.json | ConceptualCohortDefinition: BMI 30-34.9 in persons who do not achieve durable weight loss and improvement in comorbidities without surgery | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179510.json | ConceptualCohortDefinition: BMI 32.5-37.4 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities without surgery | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179509.json | ConceptualCohortDefinition: BMI 35-39.9 in persons who do not achieve durable weight loss and improvement in comorbidities without surgery | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179375.json | ConceptualCohortDefinition: Severe obesity | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179376.json | ConceptualCohortDefinition: BMI ≥ 35 and at least 1 obesity-related comorbidity | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179508.json | ConceptualCohortDefinition: BMI ≥ 37.5 kg/m2 in Asian Americans | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179512.json | ConceptualCohortDefinition: Lower BMI criteria for ADA surgery consideration | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179506.json | ConceptualCohortDefinition: BMI criteria for ADA surgery recommendation | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-170441.json | ConceptualCohortDefinition_Cancer_of_any_kind_except_basal_cell_skin_cancer_or_cancer_in_situ_unless_documented_to_be_disease_free_for_five_years | active | 2022-09 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-170442.json | ConceptualCohortDefinition_Cardiovascular_event | active | 2022-09 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-179786.json | ConceptualExposureDefinition: Therapeutic-dose anticoagulation with heparin | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179785.json | ConceptualComparatorDefinition: Usual-care pharmacologic thromboprophylaxis | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-173252.json | OutcomeDefinition: Diabetes in remission | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179799.json | MetaanalysisStudyGroup: Effect Estimates for Mortality at 14 days from COVID19 Remdesivir vs. Placebo RCTs | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-264323.json | Eligibility criteria for NMA_Diabetes | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-375279.json | Adverse event free and hypertension control | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179593.json | SearchStrategy: PubMed search for Wonder Woman | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179507.json | ConceptualCohortDefinition: Proxy criteria for surgical candidates | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-172484.json | OutcomeDefinition: HbA1c at 12 months | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-172477.json | OutcomeDefinition: HbA1c at 24 months | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-173245.json | OutcomeDefinition: HbA1c at 36 months | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-175762.json | OutcomeDefinition: HbA1c at 6 months | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-172476.json | OutcomeDefinition: HbA1c at 60 months | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-367881.json | NCT03640312 Eligibility Criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-267225.json | NCT03421379 Eligibility Criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-583769.json | NCT05327010 Eligibility Criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-189713.json | NCT04401202 Eligibility Criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-175765.json | MetaanalysisOutcomeDefinition: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups at end of follow-up | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-279340.json | ConceptualCohortDefinition: Meet either T1DM-specific eligibility criteria or T2DM-specific eligibility criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-173251.json | OutcomeDefinition: New onset depression | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-173249.json | ConceptualCohortDefinition: Nonfatal myocardial infarction | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-173250.json | ConceptualCohortDefinition: Nonfatal stroke | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-173248.json | OutcomeDefinition: Nonfatal myocardial infarction or stroke | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179562.json | EvidenceReportSubject: Clinical Outcomes for Effects of Bariatric Surgery | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179783.json | Remdesivir IV 200 mg once then 100 mg once daily for 9 days | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-265092.json | Diabetes treatment medication | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-175766.json | MetaanalysisEligibilityCriteria: Mean difference in HbA1c effect of bariatric surgery in type 2 diabetes and elevated BMI in 2016 meta-analysis | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-33395.json | MetaanalysisStudyGroup: Study results included in Mean difference in HbA1c effect of bariatric surgery in 2016 meta-analysis | active | 2022-05 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-172480.json | OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-236530.json | ComparatorDefinition: Standard care | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-236532.json | InterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-236533.json | Adults with type 2 diabetes and established CVD (but no CKD) | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-236769.json | InterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-236776.json | ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-236947.json | Adults with type 2 diabetes and CVD and CKD | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-282882.json | NHANES LBXGLU Variable Definition Cohort Definition | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-282891.json | NHANES LBDGLUSI Variable Definition Cohort Definition | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-282899.json | NHANES WTSAF2YR Variable Definition Cohort Definition | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-291368.json | OutcomeDefinition: Mortality at 14 days | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-346486.json | CTIS2024-516402-32-00 Eligibility Criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-588218.json | PICO: Intensive versus standard blood-pressure control for major adverse cardiovascular events in adults at increased cardiovascular risk | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179633.json | ComparativeEvidenceReportSubject: Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities (2018 Norwegian Cohort) | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179902.json | ConceptualCohortDefinition: At least 2 risk factors for stroke | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-297488.json | Jumping from aircraft with empty backpack | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179584.json | NetEffectContributions: Bariatric Surgery Example for GIN 2022 | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-297486.json | Jumping from aircraft with parachute | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-297750.json | OutcomeDefinition: Injury Severity Score on Impact | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179592.json | SearchStrategy: PubMed and Embase search for van Veldhuisen 2022 systematic review | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-270503.json | ConceptualCohortDefinition: T1DM or T2DM | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-279347.json | ConceptualCohortDefinition: T1DM-specific criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-279346.json | ConceptualCohortDefinition: T2DM-specific criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-267506.json | M11 IGBJ Protocol Example Eligibility Criteria | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179900.json | ConceptualCohortDefinition: Oxygen saturation below 96% on Boots Finger Pulse Oximeter with Ranges | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-179898.json | ConceptualCohortDefinition: Oxygen saturation below 96% on Boots Finger Pulse Oximeter | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-33398.json | StudyEligibilityCriteria: Type 2 diabetes and elevated BMI in 2016 meta-analysis | active | 2022-05 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-7749.json | Patients_who_are_hospitalized_for_COVID_19_and_who_are_not_critically_ill | active | 2021-08 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-7750.json | Participants_in_Anticoagulation_for_COVID_19_Combined_ATTACC_ACTIV_4a_and_REMAP_CAP_RCT_hospitalized_not_critically_ill | active | 2022-01 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-32145.json | StudyGroup: Diabetes Surgery Study Trial Enrollment Group | active | 2022-05 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-46117.json | StudyGroup_DIBASY_Trial_Enrollment_Group | active | 2022-05 | hl7 | |||
| hl7.fhir.uv.ebm | Group/Group-265093.json | Adults with diabetes mellitus type 2 | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-178427.json | StudyGroup: Severely Obese Adults 2018 Norwegian Cohort | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-307440.json | PARACHUTE Trial non participants | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-306658.json | Analyzed Group in PARACHUTE Trial | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-306660.json | Group Randomized to Comparator (empty backpack) in PARACHUTE Trial | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-370702.json | Glucagon Hydrochloride Solution (Active Comparator) | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-370701.json | Glucagon Nasal Powder (Experimental) | active | hl7 | ||||
| hl7.fhir.uv.ebm | Group/Group-306657.json | Enrolled Group PARACHUTE Trial | active | hl7 |
FHIR
FHIRsmith